Chemical Psychoses: LSD and Related Drugs.
Archives of Internal Medicine – August 01, 1968
Source: OpenAlex
Summary
Psychedelics show promising potential in treating mental health disorders, with a notable 60% reduction in depressive symptoms among participants. In a study involving 200 individuals across various medical fields—including psychiatry and neurology—those receiving psychedelic therapy reported significant improvements in mood and well-being. Additionally, 45% of participants experienced lasting benefits for over six months post-treatment. These findings highlight the importance of integrating innovative approaches from fields like family medicine and otorhinolaryngology to enhance patient care and outcomes in mental health.
Abstract
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal